Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 29, 2002

View Archived Issues

New vaccines reported effective against HPV and HSV infections

Fosamprenavir calcium combined with ritonavir safe and effective in HIV-infected patients

New data on the antiviral efficacy and safety of atazanavir in HIV infection

Teriparatide more effective than alendronate in postmenopausal osteoporosis

Antitumor efficacy of EMD-273063 alone or combined with IL-2

More than 30 years after its introduction, an antibiotic comes back as a novel neuroprotective drug

Enfuvirtide a focus of attention at recent HIV congress

Disappointing preliminary data and negative complete response letter for Replagal

Clinical development program begun for pramipexole in restless legs syndrome

FluINsure vaccine challenge trial commences

Novel opioid analgesics prepared and tested at Euroceltique

Psychotropic agents discovered by Sumitomo scientists

Wyeth presents new oxytocin antagonists with potential as tocolytic agents

New immunosuppressant and antitumor compound isolated at Takeda

BMS researchers present novel inhibitors of HIV reverse transcriptase

Orally active C5a receptor antagonist with potential in inflammatory conditions

Potential new kinase inhibitors for potentiating the effects or radio- and/or chemotherapy

Nabi files BLA for use of Nabi-HB in liver transplant patients

Drug pipeline for schizophrenia

GAM product evaluated in phase I trial for diabetic foot ulcers

Phase I findings for AP-5280 support initiation of phase I/II trial

Ortho Biotech licenses bone morphogenetic protein technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...